Cancer Research

Drawing upon the expertise of more than 300 researchers and clinicians from the Schools of Medicine, Engineering and Humanities & Sciences, the Stanford Cancer Institute is at the forefront of today's advances in cancer research and medicine.

Interdisciplinary research by Stanford experts in cancer biology, epidemiology and other fields is yielding critical insights into the origins of cancer, while collaborations between the lab and clinic are working to move the most promising discoveries into improved diagnostic, treatment and prevention strategies.

Patients seeking care at Stanford may gain early access to these emerging therapies-and the benefits that they may offer-through the center's clinical trials program.

Learn more about cancer research at the Stanford Cancer Institute including:

Our Doctors


Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Before beginning treatment, ask your doctor about any clinical trials you should consider. Learn more about clinical trials for cancer patients.

Clinical trial eligibility flowcharts

Eligibility flowcharts map clinical trials to specific types of cancers to determine if a participant is eligible for the particular clinical trial. View all cancer eligibility flowcharts at the Stanford Cancer Institute.